Suppr超能文献

与母体孕前 BMI 和孕期体重增加相关的胎盘 DNA 甲基化变化。

Placental DNA methylation changes associated with maternal prepregnancy BMI and gestational weight gain.

机构信息

Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

出版信息

Int J Obes (Lond). 2020 Jun;44(6):1406-1416. doi: 10.1038/s41366-020-0546-2. Epub 2020 Feb 18.

Abstract

BACKGROUND

Maternal obesity prior to or during pregnancy influences fetal growth, predisposing the offspring to increased risk for obesity across the life course. Placental epigenetic mechanisms may underlie these associations. We conducted an epigenome-wide association study to identify placental DNA methylation changes associated with maternal prepregnancy body mass index (BMI) and rate of gestational weight gain at first (GWG1), second (GWG2), and third trimester (GWG3).

METHOD

Participants of the NICHD Fetal Growth Studies with genome-wide placental DNA methylation (n = 301) and gene expression (n = 75) data were included. Multivariable-adjusted regression models were used to test the associations of 1 kg/m increase in prepregnancy BMI or 1 kg/week increase in GWG with DNA methylation levels. Genes harboring top differentially methylated CpGs (FDR P < 0.05) were evaluated for placental gene expression. We assessed whether DNA methylation sites known to be associated with BMI in child or adult tissues, were also associated with maternal prepregnancy BMI in placenta.

RESULTS

Prepregnancy BMI was associated with DNA methylation at cg14568196[EGFL7], cg15339142[VETZ], and cg02301019[AC092377.1] (FDR P < 0.05, P ranging from 1.4 × 10 to 1.7 × 10). GWG1 or GWG2 was associated with DNA methylation at cg17918270[MYT1L], cg20735365[DLX5], and cg17451688[SLC35F3] (FDR P < 0.05, P ranging from 6.4 × 10 to 1.2 × 10). Both prepregnancy BMI and DNA methylation at cg1456819 [EGFL7] were negatively correlated with EGFL7 expression in placenta (P < 0.05). Several CpGs previously implicated in obesity traits in children and adults were associated with prepregnancy BMI in placenta. Functional annotations revealed that EGFL7 is highly expressed in placenta and the differentially methylated CpG sites near EGFL7 and VEZT were cis-meQTL targets in blood.

CONCLUSIONS

We identified placental DNA methylation changes at novel loci associated with prepregnancy BMI and GWG. The overlap between CpGs associated with obesity traits in placenta and other tissues in children and adults suggests that epigenetic mechanisms in placenta may give insights to early origins of obesity.

摘要

背景

孕妇在怀孕前或怀孕期间的肥胖会影响胎儿的生长,使后代在整个生命过程中更容易肥胖。胎盘的表观遗传机制可能是这些关联的基础。我们进行了一项全基因组关联研究,以确定与母体孕前体重指数(BMI)和孕早期(GWG1)、孕中期(GWG2)和孕晚期(GWG3)体重增加相关的胎盘 DNA 甲基化变化。

方法

纳入了具有全基因组胎盘 DNA 甲基化(n=301)和基因表达(n=75)数据的 NICHD 胎儿生长研究的参与者。使用多变量调整回归模型来检验 1kg/m2 孕前 BMI 增加或每周 1kg 体重增加与 DNA 甲基化水平的关联。对具有最高差异甲基化 CpG(FDR P<0.05)的基因进行评估,以检测其与胎盘基因表达的关系。我们评估了在儿童或成人组织中与 BMI 相关的 DNA 甲基化位点是否也与胎盘的母体孕前 BMI 相关。

结果

孕前 BMI 与 cg14568196[EGFL7]、cg15339142[VETZ]和 cg02301019[AC092377.1]的 DNA 甲基化有关(FDR P<0.05,P 值范围为 1.4×10-5 至 1.7×10-5)。GWG1 或 GWG2 与 cg17918270[MYT1L]、cg20735365[DLX5]和 cg17451688[SLC35F3]的 DNA 甲基化有关(FDR P<0.05,P 值范围为 6.4×10-5 至 1.2×10-5)。孕前 BMI 和 cg1456819[EGFL7]的 DNA 甲基化与胎盘内 EGFL7 的表达呈负相关(P<0.05)。在儿童和成人中与肥胖特征相关的几个 CpG 位点与胎盘内的孕前 BMI 相关。功能注释显示 EGFL7 在胎盘内高表达,而 EGFL7 附近的差异甲基化 CpG 位点和 VEZT 是血液中 cis-meQTL 的靶标。

结论

我们在与孕前 BMI 和 GWG 相关的新基因座上发现了胎盘 DNA 甲基化的变化。与胎盘肥胖特征相关的 CpG 位点与儿童和成人其他组织中的肥胖特征重叠,这表明胎盘的表观遗传机制可能为肥胖的早期起源提供了新的认识。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验